Skip to content

Dr. Gwen Nichols: Addressing funding gaps in blood cancer research
Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome
Pathways & Perspectives with William Wierda, MD, PhD
How to sequence mezigdomide-based therapy in myeloma?
FDA approves rituximab biosimilar for B-cell malignancies

Insider Reader Survey

Join SOHO

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Multiple Myeloma News

Multiple Myeloma

Combination monoclonal antibody treatment induces responses but also infections in MM

by SOHO Insider Editors
March 5, 2025
0 Comments

Multiple Myeloma

A modified quadruplet therapy is feasible for older, transplant-ineligible MM patients

by SOHO Insider Editors
March 4, 2025
0 Comments

Multiple Myeloma

FDA grants Orphan Drug Designation for small-molecule MM therapy

by SOHO Insider Editors
February 27, 2025
0 Comments

Cellular Therapy Multiple Myeloma

Real-world study observes ‘superior’ outcomes with cilta-cel versus ide-cel for myeloma

by SOHO Insider Editors
February 26, 2025
0 Comments

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Abstract submissions now open for SOHO 2025

by Leah Sherwood
February 14, 2025
0 Comments

Multiple Myeloma

FDA accepts BLA review for Blenrep combo in relapsed or refractory MM

by SOHO Insider Editors
February 10, 2025
0 Comments

Multiple Myeloma

Real-world study finds this triplet therapy is an option for daratumumab-refractory myeloma

by SOHO Insider Editors
February 10, 2025
0 Comments

Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas Multiple Myeloma

Is a stronger flu vaccine better for blood cancer patients?

by Leah Sherwood
February 3, 2025
0 Comments

Cellular Therapy Multiple Myeloma News

CARTITUDE-4 findings show improved health-related quality of life with cilta-cel for multiple myeloma

by SOHO Insider Editors
January 27, 2025
0 Comments

Cellular Therapy Multiple Myeloma News

Do older patients with myeloma respond as well to ide-cel as younger patients?

by Leah Sherwood
January 14, 2025
0 Comments

1
...
9
10
11
12

Top Categories

Cellular Therapy

75

Leukemia

120

Lymphoma

137

Multiple Myeloma

116

Myelodysplastic Syndromes

44

Myeloproliferative Neoplasms

35

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Multiple Myeloma News

Combination monoclonal antibody treatment induces responses but also infections in MM

A modified quadruplet therapy is feasible for older, transplant-ineligible MM patients

FDA grants Orphan Drug Designation for small-molecule MM therapy

Real-world study observes ‘superior’ outcomes with cilta-cel versus ide-cel for myeloma

Abstract submissions now open for SOHO 2025

FDA accepts BLA review for Blenrep combo in relapsed or refractory MM

Real-world study finds this triplet therapy is an option for daratumumab-refractory myeloma

Is a stronger flu vaccine better for blood cancer patients?

CARTITUDE-4 findings show improved health-related quality of life with cilta-cel for multiple myeloma

Do older patients with myeloma respond as well to ide-cel as younger patients?

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Dr. Gwen Nichols: Addressing funding gaps in blood cancer research

Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome

Pathways & Perspectives with William Wierda, MD, PhD

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Multiple Myeloma News

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms